PIOGISTA

This brand name is authorized in Nigeria.

Active ingredients

The drug PIOGISTA contains one active pharmaceutical ingredient (API):

1	Pioglitazone UNII JQT35NPK6C - PIOGLITAZONE HYDROCHLORIDE
	Pioglitazone effects may be mediated by a reduction of insulin resistance. Pioglitazone appears to act via activation of specific nuclear receptors (peroxisome proliferator activated receptor gamma) leading to increased insulin sensitivity of liver, fat and skeletal muscle cells in animals. Treatment with pioglitazone has been shown to reduce hepatic glucose output and to increase peripheral glucose disposal in the case of insulin resistance.
	Read more about Pioglitazone

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-9917	Tablet	Piogista Tablets TAB 15 mg 3 x 10's	Tablet PIOGISTA TABLETS PIOGLITAZONE 15MG "EACH TABLET CONTAINS PIOGLITAZONE HYDROCHLORIDE USP EQ. TO PIOGLITAZONE 15 MG EXCIPIENTS CROSCARMELLOSE SODIUM USP ? SODIUM STARCH GLYCOLATE USP MICROCRYSTALLINE CELLULOSE USP ? MAGNESIUM STEARATE USP ? TALC USP ? COLLOIDAL SILICON DIOXIDE USP " B4-9917 Drugs Imported Product 3X10 02-09-2024 OKYCHRIS GLOBAL PHARMACEUTICAL LTD, 2. IHE CLOSE / OKEY EZENWANKWO STREET, AWADA OBOSI, ANAMBRA STATE. 08067654063 okychrisltd650@gmail.com SCOTT-EDIL PHARMACIA LTD, 56, EPIP, PHASE-1, JHARMAJRI, BADDI-173205, DIST. SOLAN ( H.P ) INDIA	28/02/2025

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A10BG03	Pioglitazone	A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10B Blood glucose lowering drugs, excl. insulins → A10BG Thiazolidinediones
Discover more medicines within A10BG03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-9652, B4-9917